Mannatech, Incorporated (MTEX)

Nasdaq: MTEX · Medicinal Chemicals & Botanical Products · Flower Mound, TX · filing with the SEC since 1998

Full chart Alerts Compare

Grade4.3

◀ Past 3.3● Present 4.7▶ Future 4.8

1 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2025, as filed

Revenue$108M-8.3%

Net income-$15.2M-711.0%

Earnings per share$-8.00-706.1%

Operating cash flow-$3.0M-231.0%

Cash$6.2M-45.7%

Debt$2.8M

Shareholders’ equity-$5.2M-160.6%

Shares, diluted1,901,000+0.8%

Return on equityn/a

The recordfrom its filings

Filings in 202637

Newest filingNov 12 · 8-K

Annual reportApr 15, 2026

Quarterly reportNov 12, 2026

Next report due10-K by Mar 31

Insider sales, 12 months$0.00

Insider buys, 12 months$100,000

Patents granted11

Filer categoryNon-accelerated filer<br>Smaller reporting company

Trailing twelve months to Sep 2026Revenue $103MNet income -$425,000Cash from operations -$204,000the four newest filed quarters added

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

16171819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 8-K

Results released

Open the filing on sec.gov

Nov 12, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

Oct 23, 2026 · SEC EDGAR · Form 8-K/A

Current report, amended

Open the filing on sec.gov

Oct 21, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 14, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Sep 1, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Aug 19, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Aug 19, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Aug 12, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Aug 12, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

Mannatech, Incorporated is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Flower Mound, TX. Product was 98% of fiscal 2025 revenue.

Newest on the record

Current report on Nov 12. Before it, quarterly report on Nov 12.

What is due next

The 10-K for the period to Dec 31, 2026, due by Mar 31, 2027.

About MTEX

Mannatech, Incorporated is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Flower Mound, TX. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $108 million and a loss of $15 million (its filed statements).

IndustryMedicinal Chemicals & Botanical Products

HeadquartersFlower Mound, TX

Business modelProduct business

ExchangeNasdaq

Filing since1998

Fiscal year endsDec 31

SEC number (CIK)1056358

Peers on fileRGC, BON, MDWD, SNYR

Who runs it

Financial performance

In fiscal 2025 Mannatech’s revenue was $108.0 million, down 8.3% from $117.9 million the year before. It made a net loss of $15.21 million.

Annual report, filed Apr 15, 2026.

Financial statements

The grade

Mannatech grades 4.3 of 10 against its own industry, the 20 companies in Medicinal Chemicals & Botanical Products. Eight of the nine metrics are read as filed and one is an SI estimate, each with its reasoning.

◀ Past3.3

● Present4.7

▶ Future4.8

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton MTEX · research, not advice